Stereotaxis Inc
NYSE-MKT:STXS
Stereotaxis Inc
Operating Income
Stereotaxis Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stereotaxis Inc
NYSE-MKT:STXS
|
Operating Income
-$21m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
47%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Stereotaxis Inc's Operating Income?
Operating Income
-21m
USD
Based on the financial report for Mar 31, 2024, Stereotaxis Inc's Operating Income amounts to -21m USD.
What is Stereotaxis Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-11%
Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Stereotaxis Inc have been -50% over the past three years , -43% over the past five years , and -11% over the past ten years .